ABOUT
BLOG
CATEGORIES
CONTACT
PRIVACY POLICY
RESOURCES
REVIEWS
ABOUT
BLOG
CATEGORIES
CONTACT
PRIVACY POLICY
RESOURCES
REVIEWS
START HERE
✕
Carolyn B
Home
Carolyn B
December 29, 2022
Congressional investigation into Alzheimer’s drug Aduhelm objects to FDA and Biogen
[ad_1] The report said the FDA’s approval process for Aduhelm was “riddled with irregularities” and criticized Biogen for setting an “unjustifiably high price.” [ad_2] Source link
START HERE
This website uses cookies to improve your experience. By using this website you agree to our
Data Protection Policy
.
Read more
Accept all